Eng-话题@MedSci

#Eng#

325篇内容 | 1780人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2081616, encodeId=c94120816164c, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=Front Bioeng Biotechnol：锁骨中段骨折内固定术后，仍会影响双侧肩关节运动。, objectType=article, longId=215785, objectId=9da7215e85e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9da7215e85e5, replyNumber=0, likeNumber=39, createdTime=2022-07-27, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9da7215e85e5, moduleTitle=Front Bioeng Biotechnol：锁骨中段骨折内固定术后，仍会影响双侧肩关节运动。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9da7215e85e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081623, encodeId=41992081623d1, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=N Engl J Med：度鲁特韦（Dolutegravir）作为儿童HIV-1感染的一线或二线治疗优于标准治疗, objectType=article, longId=293179, objectId=48b22931e963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48b22931e963, replyNumber=0, likeNumber=54, createdTime=2022-08-18, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48b22931e963, moduleTitle=N Engl J Med：度鲁特韦（Dolutegravir）作为儿童HIV-1感染的一线或二线治疗优于标准治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48b22931e963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081620, encodeId=64c8208162097, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=Nature Biomedical Engineering：给癌细胞穿上二氧化硅外套，用来制造癌症疫苗，可根除肿瘤，还能长期保存, objectType=article, longId=220106, objectId=a92f2201063f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a92f2201063f, replyNumber=0, likeNumber=38, createdTime=2022-05-27, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a92f2201063f, moduleTitle=Nature Biomedical Engineering：给癌细胞穿上二氧化硅外套，用来制造癌症疫苗，可根除肿瘤，还能长期保存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a92f2201063f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081622, encodeId=54d020816227c, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=New England Journal of Medicine：尼拉帕利一线维持治疗晚期卵巢癌, objectType=article, longId=220793, objectId=d997220e93d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d997220e93d1, replyNumber=0, likeNumber=29, createdTime=2022-05-31, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d997220e93d1, moduleTitle=New England Journal of Medicine：尼拉帕利一线维持治疗晚期卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d997220e93d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081610, encodeId=b6c9208161071, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=NAT BIOMED ENG：李松团队通过化学诱导肌肉干细胞扩展，帮助骨骼肌再生, objectType=article, longId=208780, objectId=ed66208e80bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed66208e80bc, replyNumber=0, likeNumber=56, createdTime=2021-05-29, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed66208e80bc, moduleTitle=NAT BIOMED ENG：李松团队通过化学诱导肌肉干细胞扩展，帮助骨骼肌再生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed66208e80bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081599, encodeId=80632081599ee, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=真实世界研究表明，在晚期前列腺癌治疗方案中增加细胞疗法PROVENGE（sipuleucel-T）可使中位生存期延长14.5个月, objectType=article, longId=202159, objectId=6ecb20215929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ecb20215929, replyNumber=0, likeNumber=32, createdTime=2021-05-16, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ecb20215929, moduleTitle=真实世界研究表明，在晚期前列腺癌治疗方案中增加细胞疗法PROVENGE（sipuleucel-T）可使中位生存期延长14.5个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ecb20215929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081607, encodeId=3f51208160ef8, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=Engrail Therapeutics收购NeuroCycle Therapeutics改进及优化药物以改善中枢神经系统疾病患者生活, objectType=article, longId=206733, objectId=aed0206e3371, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aed0206e3371, replyNumber=0, likeNumber=34, createdTime=2021-07-25, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aed0206e3371, moduleTitle=Engrail Therapeutics收购NeuroCycle Therapeutics改进及优化药物以改善中枢神经系统疾病患者生活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aed0206e3371)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081613, encodeId=b37d208161386, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=ACS Biomater. Sci. Eng.：创新伤口新辅料，或将改善抗生素预防感染新格局, objectType=article, longId=211201, objectId=fb6721120108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb6721120108, replyNumber=0, likeNumber=43, createdTime=2021-12-02, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6721120108, moduleTitle=ACS Biomater. Sci. Eng.：创新伤口新辅料，或将改善抗生素预防感染新格局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6721120108)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081615, encodeId=99042081615b9, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=NAT BIOMED ENG：朝阳医院陶勇团队等提出外泌体联合VEGF，治疗眼底新生血管性疾病, objectType=article, longId=215112, objectId=292a21511215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=292a21511215, replyNumber=0, likeNumber=35, createdTime=2022-01-19, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=292a21511215, moduleTitle=NAT BIOMED ENG：朝阳医院陶勇团队等提出外泌体联合VEGF，治疗眼底新生血管性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=292a21511215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081597, encodeId=b9fb208159e61, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=J Tissue Eng Regen Med：BMSCs衍生的外泌体对炎症和成骨的免疫调节作用, objectType=article, longId=201818, objectId=f0542018187a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0542018187a, replyNumber=0, likeNumber=27, createdTime=2020-12-05, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0542018187a, moduleTitle=J Tissue Eng Regen Med：BMSCs衍生的外泌体对炎症和成骨的免疫调节作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0542018187a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081609, encodeId=12502081609e5, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=SOLO2/ENGOT-Ov21试验终分析：奥拉帕利维持治疗卵巢癌总生存期与安慰剂相比无统计学差异！, objectType=article, longId=208701, objectId=790a208e01b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=790a208e01b0, replyNumber=0, likeNumber=45, createdTime=2021-11-21, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=790a208e01b0, moduleTitle=SOLO2/ENGOT-Ov21试验终分析：奥拉帕利维持治疗卵巢癌总生存期与安慰剂相比无统计学差异！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=790a208e01b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081611, encodeId=1e85208161126, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=N Engl J Med:氧疗对ICU死亡率的影响, objectType=article, longId=209904, objectId=56c820990476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56c820990476, replyNumber=0, likeNumber=43, createdTime=2021-09-12, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56c820990476, moduleTitle=N Engl J Med:氧疗对ICU死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56c820990476)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081614, encodeId=b1ad20816148b, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=JCO：阿替利珠单抗（Atezolizumab）+贝伐珠单抗+化疗在初始诊断III或IV期卵巢癌中的疗效和安全性：安慰剂对照随机III期研究(IMagyn050/GOG 3015/ENGOT-OV39), objectType=article, longId=212511, objectId=4d8b21251198, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d8b21251198, replyNumber=0, likeNumber=39, createdTime=2021-06-22, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d8b21251198, moduleTitle=JCO：阿替利珠单抗（Atezolizumab）+贝伐珠单抗+化疗在初始诊断III或IV期卵巢癌中的疗效和安全性：安慰剂对照随机III期研究(IMagyn050/GOG 3015/ENGOT-OV39), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d8b21251198)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081612, encodeId=67e6208161266, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=J Neuroeng Rehabil：个性化定制的互动视频游戏训练可以改善轻中度帕金森病老年患者运动能力, objectType=article, longId=209995, objectId=c65c209995ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c65c209995ce, replyNumber=0, likeNumber=49, createdTime=2021-09-18, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c65c209995ce, moduleTitle=J Neuroeng Rehabil：个性化定制的互动视频游戏训练可以改善轻中度帕金森病老年患者运动能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c65c209995ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081596, encodeId=17f3208159660, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=Mater Sci Eng C Mater Biol Appl：3D打印多孔钽和钛支架对骨整合和成骨效果, objectType=article, longId=201597, objectId=ac1b20159e8e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac1b20159e8e, replyNumber=0, likeNumber=33, createdTime=2021-05-26, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac1b20159e8e, moduleTitle=Mater Sci Eng C Mater Biol Appl：3D打印多孔钽和钛支架对骨整合和成骨效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac1b20159e8e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081592, encodeId=d3d520815928d, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=N Engl J Med：新冠疫苗mRNA-1273在非人类灵长类动物中具有显著抗病毒疗效！, objectType=article, longId=198394, objectId=cc0d19839482, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc0d19839482, replyNumber=0, likeNumber=33, createdTime=2021-03-27, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc0d19839482, moduleTitle=N Engl J Med：新冠疫苗mRNA-1273在非人类灵长类动物中具有显著抗病毒疗效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc0d19839482)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081593, encodeId=c569208159388, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=N Engl J Med：核酸检测，患者自己采样可行吗？NEJM发表详细数据对比, objectType=article, longId=198466, objectId=6bf7198466f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bf7198466f4, replyNumber=0, likeNumber=39, createdTime=2020-08-18, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bf7198466f4, moduleTitle=N Engl J Med：核酸检测，患者自己采样可行吗？NEJM发表详细数据对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bf7198466f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081602, encodeId=76032081602a4, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=Nat Biomed Eng：新突破！碱基编辑可恢复遗传性视网膜疾病损害的视觉功能！, objectType=article, longId=202621, objectId=8cbd20262180, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cbd20262180, replyNumber=0, likeNumber=44, createdTime=2021-03-26, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cbd20262180, moduleTitle=Nat Biomed Eng：新突破！碱基编辑可恢复遗传性视网膜疾病损害的视觉功能！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cbd20262180)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081601, encodeId=6f77208160177, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=Nat Biomed Eng：面部可穿戴传感器帮助肌萎缩侧索硬化（ALS）患者交流, objectType=article, longId=202518, objectId=3daa202518c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3daa202518c8, replyNumber=0, likeNumber=30, createdTime=2021-07-11, rootId=0, userName=spoonycyy, userId=3516494, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3daa202518c8, moduleTitle=Nat Biomed Eng：面部可穿戴传感器帮助肌萎缩侧索硬化（ALS）患者交流, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3daa202518c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2081594, encodeId=3160208159420, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, objectTitle=和铂医药于今年完成B+轮7500万美元融资和C轮1亿美元融资后，在Cell Engager峰会上展示其BCMAxCD3双特异性抗体, objectType=article, longId=199842, objectId=c7e719984239, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7e719984239, replyNumber=0, likeNumber=0, createdTime=2021-05-31, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7e719984239, moduleTitle=和铂医药于今年完成B+轮7500万美元融资和C轮1亿美元融资后，在Cell Engager峰会上展示其BCMAxCD3双特异性抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7e719984239)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Eng

2020-05-29

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

Front Bioeng Biotechnol：锁骨中段骨折内固定术后，仍会影响双侧肩关节运动。

2022-07-27

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

N Engl J Med：度鲁特韦（Dolutegravir）作为儿童HIV-1感染的一线或二线治疗优于标准治疗

2022-08-18

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

Nature Biomedical Engineering：给癌细胞穿上二氧化硅外套，用来制造癌症疫苗，可根除肿瘤，还能长期保存

2022-05-27

爆笑小医 (审核中...)

前往app查看评论内容

#Eng#

New England Journal of Medicine：尼拉帕利一线维持治疗晚期卵巢癌

2022-05-31

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

NAT BIOMED ENG：李松团队通过化学诱导肌肉干细胞扩展，帮助骨骼肌再生

2021-05-29

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

真实世界研究表明，在晚期前列腺癌治疗方案中增加细胞疗法PROVENGE（sipuleucel-T）可使中位生存期延长14.5个月

2021-05-16

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

Engrail Therapeutics收购NeuroCycle Therapeutics改进及优化药物以改善中枢神经系统疾病患者生活

2021-07-25

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

ACS Biomater. Sci. Eng.：创新伤口新辅料，或将改善抗生素预防感染新格局

2021-12-02

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

NAT BIOMED ENG：朝阳医院陶勇团队等提出外泌体联合VEGF，治疗眼底新生血管性疾病

2022-01-19

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

J Tissue Eng Regen Med：BMSCs衍生的外泌体对炎症和成骨的免疫调节作用

2020-12-05

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

SOLO2/ENGOT-Ov21试验终分析：奥拉帕利维持治疗卵巢癌总生存期与安慰剂相比无统计学差异！

2021-11-21

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

N Engl J Med:氧疗对ICU死亡率的影响

2021-09-12

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

JCO：阿替利珠单抗（Atezolizumab）+贝伐珠单抗+化疗在初始诊断III或IV期卵巢癌中的疗效和安全性：安慰剂对照随机III期研究(IMagyn050/GOG 3015/ENGOT-OV39)

2021-06-22

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

J Neuroeng Rehabil：个性化定制的互动视频游戏训练可以改善轻中度帕金森病老年患者运动能力

2021-09-18

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

Mater Sci Eng C Mater Biol Appl：3D打印多孔钽和钛支架对骨整合和成骨效果

2021-05-26

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

N Engl J Med：新冠疫苗mRNA-1273在非人类灵长类动物中具有显著抗病毒疗效！

2021-03-27

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

N Engl J Med：核酸检测，患者自己采样可行吗？NEJM发表详细数据对比

2020-08-18

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

Nat Biomed Eng：新突破！碱基编辑可恢复遗传性视网膜疾病损害的视觉功能！

2021-03-26

spoonycyy (审核中...)

前往app查看评论内容

#Eng#

Nat Biomed Eng：面部可穿戴传感器帮助肌萎缩侧索硬化（ALS）患者交流

2021-07-11

智智灵药 (审核中...)

前往app查看评论内容

#Eng#

和铂医药于今年完成B+轮7500万美元融资和C轮1亿美元融资后，在Cell Engager峰会上展示其BCMAxCD3双特异性抗体

2021-05-31

科室
- - 订阅+
  - 更多科室
工具
服务